Worth reading
52Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 25 June 2026Incoming appointee
2 itemsScheduled Appointment Dateアインファーマシーズ: effective 23 July 2026, subject to approval at the company's annual general meeting of shareholders. アユーララボラトリーズ: effective 1 July 2026, subject to approval at the company's extraordinary general meeting of shareholders.
Matsuoka Masaki (松岡正樹)
Previous positionAIN HOLDINGS INC. Advisor
New position株式会社アインファーマシーズ Director
Takagi Shingo (高木慎悟)
Previous position株式会社アインファーマシーズ Deputy General Manager, Retail Business Division
New positionアユーララボラトリーズ Representative Director and President
Departing officer
4 itemsDate of departureアインファーマシーズ: Directors Oishi Miya (大石美也) and Takakura Nobuyuki (髙倉信行), and Audit & Supervisory Board Member Tawaraki Tomiko (俵木登美子), are scheduled to retire effective 23 July 2026. アユーララボラトリーズ: Director Ishikawa Kaori (石川香織) is scheduled to retire effective 1 July 2026.
Oishi Miya (大石美也)Next role stated
Former PositionDirectors
New positionRetirement
Takakura Nobuyuki (髙倉信行)Next role stated
Former PositionDirectors
New positionRetirement
Tawaraki Tomiko (俵木登美子)Next role stated
Former PositionStatutory Auditors
New positionRetirement
Ishikawa Kaori (石川香織)Next role stated
Former PositionDirectors
New positionRetirement
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Reason for departure
Tawaraki Tomiko (俵木登美子) is scheduled to retire due to resignation. The reasons for the others are not disclosed.
Whether the incumbent will remain in office (whether they will retain their position)
There is no statement that they will remain on the board, and they are described as scheduled to retire.
Shareholders’ meeting approvalYes. The changes are subject to approval at the annual general meeting of shareholders of 株式会社アインファーマシーズ, scheduled for 23 July 2026, and the extraordinary general meeting of shareholders of アユーララボラトリーズ, scheduled for 1 July 2026.
| Item | Details |
|---|---|
| Resolution date | 25 June 2026 |
| Scheduled Appointment Date | アインファーマシーズ: effective 23 July 2026, subject to approval at the company's annual general meeting of shareholders. アユーララボラトリーズ: effective 1 July 2026, subject to approval at the company's extraordinary general meeting of shareholders. |
| Date of departure | アインファーマシーズ: Directors Oishi Miya (大石美也) and Takakura Nobuyuki (髙倉信行), and Audit & Supervisory Board Member Tawaraki Tomiko (俵木登美子), are scheduled to retire effective 23 July 2026. アユーララボラトリーズ: Director Ishikawa Kaori (石川香織) is scheduled to retire effective 1 July 2026. |
| Name of appointee | Matsuoka Masaki (松岡正樹), Takagi Shingo (高木慎悟) |
| Appointee's new position | 株式会社アインファーマシーズ Director, アユーララボラトリーズ Representative Director and President |
| Appointee's previous position | AIN HOLDINGS INC. Advisor, 株式会社アインファーマシーズ Deputy General Manager, Retail Business Division |
| Name of departing officer | Oishi Miya (大石美也), Takakura Nobuyuki (髙倉信行), Tawaraki Tomiko (俵木登美子), Ishikawa Kaori (石川香織) |
| Former position of departing officer | Directors, Directors, Statutory Auditors, Directors |
| New position of departing officer | Retirement, Retirement, Retirement, Retirement |
| Reason for departure | Tawaraki Tomiko (俵木登美子) is scheduled to retire due to resignation. The reasons for the others are not disclosed. |
| Whether the incumbent will remain in office | There is no statement that they will remain on the board, and they are described as scheduled to retire. |
| Subject to Approval by the General Meeting of Shareholders | Yes. The changes are subject to approval at the annual general meeting of shareholders of 株式会社アインファーマシーズ, scheduled for 23 July 2026, and the extraordinary general meeting of shareholders of アユーララボラトリーズ, scheduled for 1 July 2026. |
Items this document does not state (9)
Appointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company explains that it has decided to implement personnel changes within the group. The retirement of the Audit & Supervisory Board Member at アインファーマシーズ is due to resignation, but no reasons are provided for the other changes.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.